Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

PLoS Medicine

Volumn 9, Issue 10, 2012, Pages

  Tansey, Katherine E ^a   Guipponi, Michel ^b   Perroud, Nader ^c   Bondolfi, Guido ^c   Domenici, Enrico ^d,e   Evans, David ^f   Hall, Stephanie K ^g   Hauser, Joanna ^h   Henigsberg, Neven ⁱ   Hu, Xiaolan ^g   Jerman, Borut ^j,k   Maier, Wolfgang ^l   Mors, Ole ^m   O'Donovan, Michael ⁿ   Peters, Tim J ^f   Placentino, Anna ^o   Rietschel, Marcella ^p   Souery, Daniel ^q   Aitchison, Katherine J ^a,r   Craig, Ian ^a   Farmer, Anne ^a   Wendland, Jens R ^e   Malafosse, Alain ^b,c   Holmans, Peter ⁿ   Lewis, Glyn ^f   Lewis, Cathryn M ^a   Stensbøl, Tine Bryan ^s   Kapur, Shitij ^a   McGuffin, Peter ^a   Uher, Rudolf ^a,t   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d GSK   (Italy)

^e F Hoffmann La Roche   (Switzerland)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g PFIZER INC   (United States)

^h POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

ⁱ UNIVERSITY OF ZAGREB   (Croatia)

^j JO EF STEFAN INSTITUTE   (Slovenia)

^k NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^l UNIVERSITY OF BONN   (Germany)

^m AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁿ CARDIFF UNIVERSITY   (United Kingdom)

^o SPEDALI CIVILI   (Italy)

^p CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^q ERASME HOSPITAL   (Belgium)

^r UNIVERSITY OF ALBERTA   (Canada)

^s H LUNDBECK A S   (Denmark)

^t DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DNA INTERACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; META ANALYSIS; MULTIFACTORIAL INHERITANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINEAR MODELS; MALE; POLYMORPHISM, GENETIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84868096278     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001326     Document Type: Article

References (35)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE, (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627.
2. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905-1917.
3. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, et al. (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28-40.
4. Kato M, Serretti A, (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15: 473-500.
5. Kirchheiner J, Fuhr U, Brockmoller J, (2005) Pharmacogenetics-based therapeutic recommendations-ready for clinical practice? Nat Rev Drug Discov 4: 639-647.
6. Mrazek DA, Lerman C, (2011) Facilitating clinical implementation of pharmacogenomics. JAMA 306: 304-305.
7. Kim H, Lim SW, Kim S, Kim JW, Chang YH, et al. (2006) Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA 296: 1609-1618.
8. National Institute for Health and Clinical Excellence (2004) Depression: management of depression in primary and secondary care. London: National Institute for Health and Clinical Excellence.
9. Uher R, Tansey KE, Malki K, Perlis RH, (2012) Biomarkers predicting treatment outcome in depression: what is clinically significant? Pharmacogenomics 13: 233-240.
10. Simon GE, Perlis RH, (2010) Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 167: 1445-1455.
11. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, et al. (2010) A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67: 133-138.
12. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, et al. (2009) A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66: 966-975.
13. Hughes B, (2009) Novel consortium to address shortfall in innovative medicines for psychiatric disorders. Nat Rev Drug Discov 8: 523-524.
14. Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, et al. (2009) Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 9: 225-233.
15. Thomas L, Mulligan J, Mason V, Tallon D, Wiles N, et al. (2008) Genetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol. Trials 9: 29.
16. Perroud N, Bondolfi G, Uher R, Gex-Fabry M, Aubry JM, et al. (2011) Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics 12: 365-377.
17. Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, et al. (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167: 555-564.
18. Malki K, Uher R, Paya-Cano J, Binder E, Rietschel M, et al. (2010) Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biol Psychiatry 69: 360-365.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
20. Wittke-Thompson JK, Pluzhnikov A, Cox NJ, (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76: 967-986.
21. Royston P, Altman DG, Sauerbrei W, (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25: 127-141.
22. Streiner DL, (2002) Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry 47: 262-266.
23. Uher R, Muthen B, Souery D, Mors O, Jaracz J, et al. (2010) Trajectories of change in depression severity during treatment with antidepressants. Psychol Med 40: 1367-1377.
24. Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, et al. (2006) Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 31: 2318-2325.
25. Montgomery SA, Asberg M, (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
26. Hamilton M, (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J, (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
28. Uher R, Maier W, Hauser J, Marusic A, Schmael C, et al. (2009) Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry 194: 252-259.
29. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
30. Kallberg H, Alfredsson L, Feychting M, Ahlbom A, (2010) Don't split your data. Eur J Epidemiol 25: 283-284.
31. Dudbridge F, Gusnanto A, (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32: 227-234.
32. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, et al. (2009) Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85: 13-24.
33. Browning SR, Browning BL, (2007) Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81: 1084-1097.
34. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
35. Horstmann S, Binder EB, (2009) Pharmacogenomics of antidepressant drugs. Pharmacol Ther 124: 57-73.